v3.25.4
UNAUDITED CONDENSED STATEMENT OF CASH FLOWS - USD ($)
 5 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Cash Flows from Operating Activities:    
Net income (loss) $ (15,929) $ 415,822
Adjustments to reconcile net income to net cash used in operating activities:    
Interest earned on investments held in Trust Account (1,306,582)
Changes in operating assets and liabilities:    
Prepaid expenses (50,000) (65,606)
Other receivable (3,062) 3,062
Accounts payable and accrued expenses 7,355 99,127
Net cash used in operating activities (61,636) (854,177)
Cash Flows from Investing Activities:    
Purchase of investments held in Trust Account (82,800,000)
Net cash used in investing activities (82,800,000)
Cash Flows from Financing Activities:    
Proceeds from sale of public units 82,800,000
Proceeds from sale of Private Placements units 2,286,500
Payment of underwriter fees (586,500)
Proceeds from issuance of founder shares to Sponsor 25,000
Repayment of promissory note – related party (200,000)
Proceeds from promissory note – related party 200,000
Payment of offering costs (11,563) (429,007)
Net cash provided by financing activities 213,437 83,870,993
Net Changes in Cash 151,801 216,816
Cash – Beginning of period 64,357
Cash – End of period 151,801 281,173
Supplemental Disclosure of Non-cash Financing Activities:    
Accretion of additional paid in capital to accumulated deficit 3,454,465
Remeasurement of carrying value to redemption value 7,567,493
Deferred underwriting fee payable 3,312,000
Prior year deferred offering cost charged to additional paid-in capital $ 131,563